On October 27, 2020, Synex Medical announced the closing of a $5.25 million Seed financing round. The financing will be used to develop a non-invasive blood monitoring technology as well as growing the team and expanding into the U.S.
Synex Medical was founded by CEO Ben Nashman in 2017 with the vision of providing people with constant data about how their bodies are functioning.
Osler, Hoskin & Harcourt LLP advised Synex Medical with a team consisting of Chad Bayne and Kosta Starostin (Emerging and High Growth Companies).
Key Contact
Chad Bayne
Partner, Emerging and High Growth Companies, Toronto
